Senior Manager LabCorp Drug Development - Bioanalytical Services Madison, Wisconsin
A high-level overview of three case studies highlighting LC-MS approaches and advances for the bioanalysis of large molecule therapeutics: (1) Aptamers for hybrid LBA/LC-MS analysis, (2) Overcoming analytical challenges for oligonucleotide analysis, and (3) Nanoflow HRMS for peptide quantitation.
Learning Objectives:
Hybrid LBA/LC-MS workflows - How can we improve upon the standard workflows?
Oligonucleotide therapeutic bioanalysis - How can we mitigate typical analytical challenges?
Nanoflow LC-HRMS – What are the practical considerations of nanoflow LC in a regulated, high throughput laboratory?